Hyloris Pharmaceuticals
Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company.
Business Model:
Revenue: $3.5M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Hyloris Pharmaceuticals Information
Geographic Data
Address: Boulevard Gustave, Kleyer 17
City: Li Ge
State: liège
Zip: 4000
Country: BE
Financial Info
Stage:
Raised Last:
$17M
Raised Total:$33M
Social
Facebook
Linkedin
Crunchbase
Metrics
8,559,813Website Global Rank
290Website Monthly Traffic
Twitter Followers
Description
Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. Hyloris Pharmaceuticals develop innovative proprietary products that offer significant advantages compared to currently available alternatives.
Contact Phone:
Contact Email:
Hyloris Pharmaceuticals went public on 6/29/2020 on the EBR
Listed Exchange:
EBR
IPO Date:
6/29/2020
Ticker Symbol:
HYL
IPO Price:
$12.090416067769313/share
Amount Raised:
$70M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2022 | Pleco Therapeutics | Series A | 0 |
| 9/2022 | Pleco Therapeutics | Series A | 0 |
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
